MARC L SPERO

Allopathic & Osteopathic Physicians|Internal Medicine NEW YORK, NY NPI 1831175009

General Payments — all program years on this page

$7,636.93

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 454
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $451.83 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $451.8320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,381.9881
2019 $1,845.61115
2020 $1,181.1172
2021 $1,104.8569
2022 $1,050.2856
2023 $621.2741
2024 $451.8320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078441525 Janssen Biotech, Inc. $14.17 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078456022 Janssen Biotech, Inc. $34.91 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106146759 ABBVIE INC. $20.62 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106146761 ABBVIE INC. $18.67 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106146763 ABBVIE INC. $13.72 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116304145 GlaxoSmithKline, LLC. $19.97 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116375480 GlaxoSmithKline, LLC. $22.65 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125518039 Braintree Laboratories, Inc. $21.95 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137680631 Takeda Pharmaceuticals U.S.A., Inc. $14.68 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137680633 Takeda Pharmaceuticals U.S.A., Inc. $22.79 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141677701 Merck Sharp & Dohme LLC $30.12 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141677703 Merck Sharp & Dohme LLC $24.90 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141677705 Merck Sharp & Dohme LLC $21.89 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141863839 Merck Sharp & Dohme LLC $32.66 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147712218 QOL Medical, LLC $29.09 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147712220 QOL Medical, LLC $29.79 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147712222 QOL Medical, LLC $25.61 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153674944 Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.50 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153682707 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.44 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153764923 IRONWOOD PHARMACEUTICALS, INC $25.70 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.